Invitrocue
Biotechnology Research • 
Queenstown, Central Region, Singapore • 21-50 Employees
Company overview
| Headquarters | 51 Science Park Rd,, #01-11/13 The Aries, Singapore Science Park II,, Singapore , Singapore 117586, US |
| Phone number | +6568190181 |
| Website | |
| NAICS | 541714 |
| SIC | 283 |
| Keywords | Contract Research Organization, Safety Assessment, Patient-Derived Organoids, Personalized Oncology, Onco-Pdo Test, Pdo-Derived Xenograft, Pharmacology Services |
| Founded | 2012 |
| Employees | 21-50 |
| Socials |
Key Contacts at Invitrocue
Jing Yuan Chooi
Associate Director, Scientific Affairs And Laboratory Operations
Callie Cooper
Operations Director
Invitrocue Sg
Associate Director, Invitrocue
Invitrocue Email Formats
Invitrocue uses 3 email formats. The most common is {first name}.{last name} (e.g., john.doe@invitrocue.com), used 60% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}.{last name} | john.doe@invitrocue.com | 60% |
{first initial}.{last name} | j.doe@invitrocue.com | 33.3% |
{first name} | john@invitrocue.com | 6.7% |
About Invitrocue
An innovative life sciences company that specialises in developing ground-breaking 3D cell-based models such as Patient-Derived Organoids from all solid cancers. By utilizing Onco-PDO test, we perform in vitro drug screenings on PDOs to provide the oncologists with the information to better direct patient therapy and personalized patient treatment. By enabling assessments of the best ways for drugs to be developed, we impart to the industry valuable knowledge in creating better, faster and more affordable disease treatments, working towards the company’s goal of creating a healthier society by providing patients with the best possible care. Headquartered in Singapore and with operations in Australia, China, Hong Kong and Germany, Invitrocue’s Onco-PDO technology enables patient-derived cancer cells (organoids) to be cultured in laboratories for testing against a panel of drugs to support personalised clinical decisions. By enabling assessments of the best ways for drugs to be developed, Invitrocue creates better, faster and more affordable disease treatments, that work towards the company’s goal of creating a healthier society by providing patients with the best possible care. To learn more please visit: https://www.invitrocue.com
Invitrocue revenue & valuation
| Annual revenue | $540,000 |
| Revenue per employee | $18,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $1,800,000 |
| Total funding | No funding |
Employees by Management Level
Total employees: 21-50
Seniority
Employees
Employees by Department
Invitrocue has 14 employees across 7 departments.
Departments
Number of employees
Funding Data
Invitrocue has never raised funding before.
Invitrocue Tech Stack
Discover the technologies and tools that power Invitrocue's digital infrastructure, from frameworks to analytics platforms.
CDN
Security
JavaScript libraries
Page builders
JavaScript libraries
Web servers
JavaScript libraries
WordPress themes
Programming languages
Security
WordPress plugins
France
United Arab Emirates
Serbia
Canada
Frequently asked questions
4.8
40,000 users
